Treatment of Extended-Spectrum Beta-Lactamase Enterobacteriaceae With Cefepime: The Dose Matters, Too

被引：6

作者：

Altshuler, Jerry ^{[1
]}

Aitken, Samuel L. ^{[2
,3
]}

Guervil, David ^{[1
]}

Esaian, Diana ^{[4
]}

Papadopoulos, John ^{[4
]}

Arias, Cesar A. ^{[5
]}

机构：

[1] Mem Hermann, Texas Med Ctr, Houston, TX 77030 USA

[2] St Lukes Episcopal Hosp, Houston, TX 77030 USA

[3] Univ Houston, Coll Pharm, Houston, TX 77030 USA

[4] NYU, Langone Med Ctr, New York, NY USA

[5] Univ Texas Med Sch, Houston, TX USA

来源：

CLINICAL INFECTIOUS DISEASES | 2013年 / 57卷 / 06期

关键词：

BREAKPOINTS; ORGANISMS; RATIONALE;

D O I：

10.1093/cid/cit383

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

071005 [微生物学]; 100108 [医学免疫学];

摘要：

引用

页码：915 / 916

页数：2

共 5 条

[1]

Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations [J].

Andes, D ;

Craig, WA .

CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 :10-17

[2]

Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms [J].

Bhat, Sunil V. ;

Peleg, Anton Y. ;

Lodise, Thomas P., Jr. ;

Shutt, Kathleen A. ;

Capitano, Blair ;

Potoski, Brian A. ;

Paterson, David L. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (12) :4390-4395

[3]

Background and Rationale for Revised Clinical and Laboratory Standards Institute Interpretive Criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam [J].

Dudley, Michael N. ;

Ambrose, Paul G. ;

Bhavnani, Sujata M. ;

Craig, William A. ;

Ferraro, Mary Jane ;

Jones, Ronald N. .

CLINICAL INFECTIOUS DISEASES, 2013, 56 (09) :1301-1309

[4]

Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: MIC Matters [J].

Lee, Nan-Yao ;

Lee, Ching-Chi ;

Huang, Wei-Han ;

Tsui, Ko-Chung ;

Hsueh, Po-Ren ;

Ko, Wen-Chien .

CLINICAL INFECTIOUS DISEASES, 2013, 56 (04) :488-495

[5]

Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units [J].

Roos, Juliana F. ;

Bulitta, Jurgen ;

Lipman, Jeffrey ;

Kirkpatrick, Carl M. J. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (05) :987-993

← 1 →